Cargando…
Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia
OBJECTIVE. To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105594/ https://www.ncbi.nlm.nih.gov/pubmed/37082532 http://dx.doi.org/10.26633/RPSP.2023.10 |
_version_ | 1785026244464607232 |
---|---|
author | Hurtado, Isabel Cristina Valencia, Sandra Pinzon, Elisa Maria Lesmes, Maria Cristina Sanchez, Mauro Rodriguez, Jaime Ochoa, Brindis Shewade, Hemant Deepak Edwards, Jeffrey K. Hann, Katrina Khogali, Mohammed |
author_facet | Hurtado, Isabel Cristina Valencia, Sandra Pinzon, Elisa Maria Lesmes, Maria Cristina Sanchez, Mauro Rodriguez, Jaime Ochoa, Brindis Shewade, Hemant Deepak Edwards, Jeffrey K. Hann, Katrina Khogali, Mohammed |
author_sort | Hurtado, Isabel Cristina |
collection | PubMed |
description | OBJECTIVE. To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March 2020 to July 2021) the COVID-19 pandemic in 31 hospitals in Valle del Cauca, Colombia. METHODS. This was a before/after study using routinely collected data. For antibiotic consumption, daily defined doses (DDD) per 100 bed-days were compared. RESULTS. There were 23 405 priority bacterial isolates with data on antibiotic resistance. The total number of isolates increased from 9 774 to 13 631 in the periods before and during the pandemic, respectively. While resistance significantly decreased for four selected bug-drug combinations (Klebsiella pneumoniae, extended spectrum beta lactamase [ESBL]-producing, 32% to 24%; K. pneumoniae, carbapenem-resistant, 4% to 2%; Pseudomonas aeruginosa, carbapenem-resistant, 12% to 8%; Acinetobacter baumannii, carbapenem-resistant, 23% to 9%), the level of resistance for Enterococcus faecium to vancomycin significantly increased (42% to 57%). There was no change in resistance for the remaining three combinations (Staphylococcus aureus, methicillin-resistant; Escherichia coli, ESBL-producing; E. coli, carbapenem-resistant). Consumption of all antibiotics increased. However, meropenem consumption decreased in intensive care unit settings (8.2 to 7.1 DDD per 100 bed-days). CONCLUSIONS. While the consumption of antibiotics increased, a decrease in antibiotic resistance of four bug-drug combinations was observed during the pandemic. This was possibly due to an increase in community-acquired infections. Increasing resistance of E. faecium to vancomycin must be monitored. The findings of this study are essential to inform stewardship programs in hospital settings of Colombia and similar contexts elsewhere. |
format | Online Article Text |
id | pubmed-10105594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-101055942023-04-19 Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia Hurtado, Isabel Cristina Valencia, Sandra Pinzon, Elisa Maria Lesmes, Maria Cristina Sanchez, Mauro Rodriguez, Jaime Ochoa, Brindis Shewade, Hemant Deepak Edwards, Jeffrey K. Hann, Katrina Khogali, Mohammed Rev Panam Salud Publica Original Research OBJECTIVE. To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March 2020 to July 2021) the COVID-19 pandemic in 31 hospitals in Valle del Cauca, Colombia. METHODS. This was a before/after study using routinely collected data. For antibiotic consumption, daily defined doses (DDD) per 100 bed-days were compared. RESULTS. There were 23 405 priority bacterial isolates with data on antibiotic resistance. The total number of isolates increased from 9 774 to 13 631 in the periods before and during the pandemic, respectively. While resistance significantly decreased for four selected bug-drug combinations (Klebsiella pneumoniae, extended spectrum beta lactamase [ESBL]-producing, 32% to 24%; K. pneumoniae, carbapenem-resistant, 4% to 2%; Pseudomonas aeruginosa, carbapenem-resistant, 12% to 8%; Acinetobacter baumannii, carbapenem-resistant, 23% to 9%), the level of resistance for Enterococcus faecium to vancomycin significantly increased (42% to 57%). There was no change in resistance for the remaining three combinations (Staphylococcus aureus, methicillin-resistant; Escherichia coli, ESBL-producing; E. coli, carbapenem-resistant). Consumption of all antibiotics increased. However, meropenem consumption decreased in intensive care unit settings (8.2 to 7.1 DDD per 100 bed-days). CONCLUSIONS. While the consumption of antibiotics increased, a decrease in antibiotic resistance of four bug-drug combinations was observed during the pandemic. This was possibly due to an increase in community-acquired infections. Increasing resistance of E. faecium to vancomycin must be monitored. The findings of this study are essential to inform stewardship programs in hospital settings of Colombia and similar contexts elsewhere. Organización Panamericana de la Salud 2023-04-19 /pmc/articles/PMC10105594/ /pubmed/37082532 http://dx.doi.org/10.26633/RPSP.2023.10 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/us/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license. |
spellingShingle | Original Research Hurtado, Isabel Cristina Valencia, Sandra Pinzon, Elisa Maria Lesmes, Maria Cristina Sanchez, Mauro Rodriguez, Jaime Ochoa, Brindis Shewade, Hemant Deepak Edwards, Jeffrey K. Hann, Katrina Khogali, Mohammed Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title | Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title_full | Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title_fullStr | Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title_full_unstemmed | Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title_short | Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia |
title_sort | antibiotic resistance and consumption before and during the covid-19 pandemic in valle del cauca, colombia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105594/ https://www.ncbi.nlm.nih.gov/pubmed/37082532 http://dx.doi.org/10.26633/RPSP.2023.10 |
work_keys_str_mv | AT hurtadoisabelcristina antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT valenciasandra antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT pinzonelisamaria antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT lesmesmariacristina antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT sanchezmauro antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT rodriguezjaime antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT ochoabrindis antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT shewadehemantdeepak antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT edwardsjeffreyk antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT hannkatrina antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia AT khogalimohammed antibioticresistanceandconsumptionbeforeandduringthecovid19pandemicinvalledelcaucacolombia |